1. Market Research
  2. > Pharmaceutical
  3. > Drug and Medication Market Trends
  4. > Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors
Product description

Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for parathyroid hormone (PTH) and for parathyroid hormone-related protein (PTHrP). FORTEO (teriparatide) is recombinant human parathyroid hormone analog (1-34), marketed since 2002 for the treatment of osteoporosis and related indications where an increase of bone mass is desirable. With 2012 sales of over US$ 1 bln and the forthcoming patent expiry, teriparatide is an attractive target for biosimilar developments as well as for next generation improved PTH receptor agonist products.

The present Competitive Intelligence report about PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors provides a competitor evaluation in the field of protein- and peptide-based agonists  of the parathyroid hormone (PTH) receptor for the treatment of osteoporosis as of October 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of proteins and peptides as agonists of the parathyroid hormone (PTH) receptor. In addition, the report lists company-specific R&D pipelines of PTH receptor agonists.

Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors
Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

Table of Contents

• 1st Generation PTH Receptor Agonists
• Teriparatide Biosimilars
• PTH-related Proteins/Peptides
• PTH Variants
• Nasal Drug Delivery Solutions for rhPTH Receptor Agonists
• Oral Drug Delivery Solutions for rhPTH Receptor Agonists
• Transdermal Drug Delivery Solutions for rhPTH Receptor Agonists
• Corporate PTH Receptor Agonist RandD Pipelines

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2015-2019 Europe Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Competitive Landscape, Supplier Shares, Country Segment Forecasts,  Innovative Technologies, Instrumentation

2015-2019 Europe Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Competitive Landscape, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation

  • $ 12 800
  • Industry report
  • July 2015
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the ...

Testosterone acetate Chemical Report

Testosterone acetate Chemical Report

  • $ 4 609
  • Industry report
  • July 2015
  • by PureData

Testosterone acetate Chemical Report This Testosterone acetate Chemical World Consumption Reportt provides data on the net consumption of Testosterone acetate in each of the countries listed. The substance ...

Leukemia Treatment Drugs Markets in China

Leukemia Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.